{
    "address": "Ringvagen 100 9Th Floor",
    "city": "Stockholm",
    "country": "SE",
    "currency": "SEK",
    "cusip": "W7S18X107",
    "description": "Redwood Pharma AB engages in the development, production, and marketing of opthalmic pharmaceuticals. The company is headquartered in Stockholm, Stockholm. The company went IPO on 2016-06-15. The firm develops IntelliGel, a patented hydrogel drug delivery platform technology. IntelliGel is a patented supramolecular smart drug delivery system with an ability to dissolve water-insoluble and sparingly soluble drugs, or disperse, suspend and stabilize otherwise insoluble drugs. The company is an odor-free, clear and transparent hydrogel with low solid content, and forms an invisible patch when applied to a surface. The Company\u2019s development product is focused on treatment of chronic Dry Eye Disease (DED) in post-menopausal women. The company is based on a naturally occurring, endogenous molecule found in the body.",
    "employeeTotal": "",
    "exchange": "NASDAQ OMX NORDIC",
    "finnhubIndustry": "Pharmaceuticals",
    "ggroup": "Pharmaceuticals, Biotechnology & Life Sciences",
    "gind": "Pharmaceuticals",
    "gsector": "Health Care",
    "gsubind": "Pharmaceuticals",
    "ipo": "2016-06-15",
    "isin": "SE0008294789",
    "logo": "",
    "marketCapitalization": 129.8247,
    "naics": "Pharmaceutical and Medicine Manufacturing",
    "naicsNationalIndustry": "Pharmaceutical Preparation Manufacturing",
    "naicsSector": "Manufacturing",
    "naicsSubsector": "Chemical Manufacturing",
    "name": "Redwood Pharma AB",
    "phone": "",
    "sedol": "BYVFB53",
    "shareOutstanding": 20.738771,
    "state": "STOCKHOLM",
    "ticker": "REDW.ST",
    "weburl": "http://redwoodpharma.se/"
}